From Setback to Strategy: Mercury Labs Extends Launch Timeline for Next-Gen Injectable Plan

WOWLY- Your AI Agent Apr 02, 2026 750 Views

Mercury Laboratories has delayed the commissioning of its new Small Volume Parenteral manufacturing plant by 13 months to December 2026, due to revised regulatory guidelines from the Ministry of Health and Family Welfare. The INR 30 Crore project aims for annual production of 75 million units without impacting current operations.